亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

無錫同創生物科技有限公司  

辣根過氧化物酶,5-溴-4氯-3吲哚-神經氨酸,吡咯酯等

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:張倩
  • 電話:13655185676
  • 郵件:wuxitongchuang@yahoo.cn
  • 傳真:0510-85899582
  • QQ:1760363918
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 1-乙基-(3-二甲基氨基丙基)碳酰二亞胺***
1-乙基-(3-二甲基氨基丙基)碳酰二亞胺***
單價 面議對比
詢價 暫無
發貨 江蘇無錫市付款后3天內
過期 長期有效
更新 2024-01-10 11:53
 
詳細信息

中文名稱:1-乙基-(3-二甲基氨基丙基)碳酰二亞胺***

英文名稱:1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride

CAS:25952-53-8

分子式:C8H18ClN3

分子量: 191.7

規格:1KG/瓶

外觀:白色結晶粉末

熔點:110.0-115.0°C(dec.)

含量:≥99.0%

干燥失重:≤0.5%

注意事項:易吸水,避免光線,儲存在陰涼干燥的地方(≤10℃)

產品應用:蛋白質和核酸交聯試劑,可實現快速多肽縮合反應的水溶性碳二亞胺型縮合劑。EDC(或EDAC)的分子呈線性結構,用于羧基與伯胺的縮合反應,并已獲得廣泛的用途。

©2025 無錫同創生物科技有限公司 版權所有   技術支持:化工網   訪問量:36595  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |